Business · 19/05/1997
FDA Publishes Guideline for Periodic Safety Update Reports for Marketed Drugs
The FDA is releasing a new guideline to standardize the reporting of postmarketing safety data for pharmaceuticals, developed under the International Conference on Harmonisation, to improve data collection and submission.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →